Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Opinion
New weight loss drugs raise questions of access, costs
New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health risks posed by obesity. Yet the drugs are so expensive that insurers are often choosing between two bad options: restricting access or raising consumer costs.
Study: GLP-1 weight-loss drugs might lower, not increase, teen suicide risk
In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and suicide attempts compared to adolescents who didn't.
Cost-effectiveness of combining weight loss drugs and surgery
Newer weight loss drugs are cost effective in the long term only when combined with bariatric weight loss surgery, according to a study presented at the American College of Surgeons (ACS) Clinical Congress 2024 in San Francisco,
Weight Loss Drugs Like Ozempic, Wegovy May Help Fight Alcoholism and Opioid Addiction
A new study reveals that glucagon-like peptide-1 receptor agonists (GLP-1), which include weight loss and diabetes meds Ozempic, Wegovy, Mounjaro or Zepbound, may help users overcome alcoholism and opioid addiction.
Wegovy, other weight-loss drugs might help with alcoholism, opioid addiction
Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid addiction, a new study finds.
Weight loss drugs like Ozempic may help reduce overdose risks: Study
A study suggests that weight loss medications like Ozempic may help reduce the risk of overdose and alcohol intoxication in people with substance use disorders.
GLP-1 Stocks Aren't the Only Way to Benefit From the Weight Loss Drugs Boom
The future of the weight loss market might not revolve around GLP-1 drugs.
Not Many Employers Cover GLP-1 Weight Loss Drugs
Fewer than 20% of large employers are covering GLP-1 weight loss drugs like Ozempic, a new KFF analysis shows.
Weight-loss drugs may reduce opioid and alcohol abuse by up to 50%, study finds
Weight-loss drugs such as Ozempic, made by Denmark’s Novo Nordisk, can reduce rates of opioid and alcohol abuse by up to 50%, according to a new study that supports expectations the drugs can offer greater benefits than just weight and diabetes management.
Weight-Loss Drugs Cut Drug and Alcohol Abuse, According to New Study
Drugs such as Novo Nordisk’s Ozempic can cut drug and alcohol abuse by up to 50%, a study found, adding to mounting evidence that the drugs yield health benefits beyond diabetes and weight loss.
Weight loss drugs may help reduce drug and alcohol misuse: Research
Weight loss medications such as Ozempic may be able to cut drug and alcohol misuse in half, according to a new study from the scientific journal Addiction. The research, published Thursday, found that people who take Ozempic or similar drugs — those used for weight loss or treating Type 2 diabetes — were 40
Healthline
2d
Ozempic Microdosing Is Gaining Popularity. Does It Work for Weight Loss?
What health experts think of the growing Ozempic “microdosing” trend that claims taking very small doses of GLP-1 drugs can ...
News Medical on MSN
3d
Expanding access to GLP-1 weight-loss drugs could save thousands of lives
Researchers estimate that expanding access to weight-loss drugs could save over 50,000 lives annually, reducing obesity rates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Reaches tentative union deal
G7 ministers back Ukraine
La Nina could arrive soon
Frozen waffles recalled
Postpones US tour
Nationwide blackout in Cuba
Challenges military listing
PG&E shuts off power
Netanyahu's home targeted
Republicans appeal ruling
Antitrust ruling delayed
At decade-high level
Probes near miss in Austin
US deficit reaches $1.8T
NYC Halloween dog parade
Boat rider arrested in FL
Calif. oil refinery closure
MS after game shooting
Fire prompts evacuations
Hurricane Oscar forms
Three Americans detained
NK sending troops to RU?
Judge unseals new evidence
OK classroom Bible suit
Opioid suits settlement deal
$4M LAPD fentanyl seizure
NC breaks turnout record
Bladder cancer drug pulled
Philip Zimbardo dies at 91
School shooting report
To furlough 700 workers
2024 induction ceremony
Ex-MN congressman dies
Emergency abortion ruling
Feedback